Moran Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Moran Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-644	Closed	-$312K	–	516
2025 Q1	$312K	Sell	644 -29,300	-98%	-$13.7M	0.01%	397
2024 Q4	$12.1M	Buy	29,944 +866	+3%	+$401K	0.38%	90
2024 Q3	$13.5M	Buy	29,078 +459	+2%	+$220K	0.42%	83
2024 Q2	$13.4M	Buy	28,619 +1,274	+5%	+$553K	0.44%	75
2024 Q1	$11.4M	Buy	27,345 +438	+2%	+$185K	0.37%	92
2023 Q4	$10.9M	Buy	26,907 +1,962	+8%	+$725K	0.39%	89
2023 Q3	$8.67M	Buy	24,945 +945	+4%	+$330K	0.34%	107
2023 Q2	$8.45M	Sell	24,000 -445	-2%	-$150K	0.32%	110
2023 Q1	$7.7M	Buy	24,445 +9,015	+58%	+$2.7M	0.29%	118
2022 Q4	$4.46M	Buy	+15,430	New	+$4.7M	0.17%	164

Other funds holding VRTX

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return